Your Shopping Cart Is Empty
| Report Code: A00281 | May 2021 | Pages: 307 | ||
| Tables: 241 | Charts: 61 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Dialysis Market
Request Now !The global dialysis market size was valued at $91,205.0 million in 2020, and is estimated to reach $129,756.8 million by 2028, registering a CAGR of 4.7% from 2021 to 2028. Dialysis is a technique used to remove waste products, such as urea and creatinine from the blood due to abnormal functioning of the kidneys and is usually required for people suffering from chronic renal failure. The procedure is important during the treatment of end-stage renal disease (ESRD) and kidney transplant. In this procedure, the blood is purified, excess fluid and toxins are removed, and electrolyte balance is restored. Dialysis is carried out in two ways, namely, hemodialysis and peritoneal dialysis. In hemodialysis, waste products such as urea are removed extracorporeally from the blood of the patient. In peritoneal dialysis, the peritoneum in the abdomen is used for dialysis.
The market growth is attributed to the increase in number of diabetic and hypertension patients, surge in funding for the development of new products, and a rise in the number of end stage renal disease (ESRD) patients. Furthermore, dialysis is a preferred technique over kidney transplantation, which is expected to further boost the dialysis market growth. Moreover, the rise in geriatric population, increase in healthcare expenditure, and growth in disposable income are expected to fuel the market growth. However, lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to hinder the market growth.
The dialysis market is segmented on the basis of type, Product & Service, end user, and region. On the basis of type, it is bifurcated into hemodialysis and peritoneal dialysis. Hemodialysis is categorized into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is further classified into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). On the basis of Product & Service, it is divided into equipment, consumables, drugs, and services. Equipment is further categorized into dialysis machines, water treatment systems, and others. Consumables are classified into dialyzers, catheters, and transfer sets. On the basis of end users, it is bifurcated into in-center dialysis and home dialysis. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The hemodialysis segment is the major contributor toward the dialysis market growth, owing to maturity of the market and is a preferred form of approach among healthcare professionals and patients suffering from ESRD. There are two types of hemodialysis, namely, conventional and daily (short daily and nocturnal hemodialysis). Majority of patients opt for hemodialysis, however, owing to efficient removal of toxic substances and rise in demand for homecare among dialysis patients, peritoneal dialysis is expected to be the fastest growing segment during the forecast period.
The services segment was the highest contributor toward market growth in 2020 and is expected to maintain its dominance during the forecast period. Increase in number of treatment centers and advancement of home-based services are the factors attributing toward the dominance of the services segment.
Most patients prefer to receive dialysis treatments through services provided by dialysis centers making them the largest contributor to the global dialysis market. Nonetheless, rise in awareness and surge in demand for home healthcare among dialysis patients is expected to make home dialysis the fastest growing segment during the forecast period.
In 2020, Asia-Pacific accounted for maximum contribution to the total revenue generated owing to high prevalence rate of diabetes and hypertension, presence of high disposable income, and high adoption rate of technologically advanced products. Moreover, the presence of large number of dialysis centers in this region and a rise in number of patients with chronic renal and kidney diseases are expected to boost market growth. Moreover, the Asia-Pacific region is expected to witness the highest CAGR during the analysis period, which is attributed to a surge in the incidence rate of kidney failure, low rate of organ transplantation, and rise in healthcare expenditure.
Key Benefits For Stakeholders
The key players that operate in the global Dialysis Market include FRESENIUS SE AND CO. KGAA, ASAHI KASEI CORPORATION, B. BRAUN MELSUNGEN AG, BAXTER INTERNATIONAL INC., BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.), DAVITA, ANGIODYNAMICS INC., DIAVERUM DEUTSCHLAND GmbH., NIKKISO CO. LTD., NIPRO CORPORATION
Dialysis Market Report Highlights
| Aspects | Details |
|---|---|
| By Type |
|
| By PRODUCT AND SERVICES |
|
| By END USERS |
|
| By Region |
|
| Key Market Players | NIKKISO CO. LTD., BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.), FRESENIUS SE AND CO. KGAA, ASAHI KASEI CORPORATION, ANGIODYNAMICS INC., DAVITA, DIAVERUM DEUTSCHLAND GmbH., NIPRO CORPORATION, B. BRAUN MELSUNGEN AG, BAXTER INTERNATIONAL INC. |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Surge in incidences of kidney diseases
3.5.1.2.Issues associated with kidney transplants
3.5.1.3.Rise in prevalence of lifestyle and chronic diseases
3.5.2.Restraints
3.5.2.1.Complications in dialysis treatment
3.5.2.2.Reimbursement policy concerns in emerging nations
3.5.3.Opportunities
3.5.3.1.Shift in preference of patients for home hemodialysis
3.5.3.2.Surge in market strategies by key players
3.6.Reimbursement scenario for dialysis (per patient)
3.7.COVID 19 Impact on the Market
CHAPTER 4:DIALYSIS MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Hemodialysis (HD)
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.3.1.Conventional Hemodialysis
4.2.3.1.1.Market size and forecast
4.2.3.2.Short daily hemodialysis
4.2.3.2.1.Market size and forecast
4.2.3.3.Nocturnal hemodialysis
4.2.3.3.1.Market size and forecast
4.3.Peritoneal dialysis (PD)
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
4.3.3.1.Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.3.1.1.Market size and forecast
4.3.3.2.Automated Peritoneal Dialysis (APD)
4.3.3.2.1.Market size and forecast
CHAPTER 5:DIALYSIS MARKET, BY PRODUCT AND SERVICES
5.1.Overview
5.1.1.Market size and forecast
5.2.EQUIPMENT
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Market share analysis, by country
5.2.4.Dialysis Machines
5.2.4.1.Market size and forecast
5.2.5.Water Treatment Systems
5.2.5.1.Market size and forecast
5.2.6.Others dialysis equipment
5.2.6.1.Market size and forecast
5.3.Consumables
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market share analysis, by country
5.3.4.Dialyzers
5.3.4.1.Market size and forecast
5.3.5.Catheters
5.3.5.1.Market size and forecast
5.3.6.Other dialysis consumables
5.3.6.1.Market size and forecast
5.4.Dialysis Drugs
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market share analysis, by country
5.5.Services
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.5.3.Market share analysis, by country
CHAPTER 6:DIALYSIS MARKET, BY END USERS
6.1.Overview
6.1.1.Market size and forecast
6.2.In-center dialysis
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country
6.3.Home dialysis
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country
CHAPTER 7:DIALYSIS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by type
7.2.4.Market size and forecast, by products and services
7.2.5.Market size and forecast, by end user
7.2.6.U.S.
7.2.6.1.Market size and forecast, by type
7.2.6.2.Market size and forecast, by products and services
7.2.6.3.Market size and forecast, by end user
7.2.7.Canada
7.2.7.1.Market size and forecast, by type
7.2.7.2.Market size and forecast, by products and services
7.2.7.3.Market size and forecast, by end user
7.2.8.Mexico
7.2.8.1.Market size and forecast, by type
7.2.8.2.Market size and forecast, by products and services
7.2.8.3.Market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by type
7.3.4.Market size and forecast, by products and services
7.3.5.Market size and forecast, by end user
7.3.6.UK
7.3.6.1.Market size and forecast, by type
7.3.6.2.Market size and forecast, by products and services
7.3.6.3.Market size and forecast, by end user
7.3.7.France
7.3.7.1.Market size and forecast, by type
7.3.7.2.Market size and forecast, by products and services
7.3.7.3.Market size and forecast, by end user
7.3.8.Spain
7.3.8.1.Market size and forecast, by type
7.3.8.2.Market size and forecast, by products and services
7.3.8.3.Market size and forecast, by end user
7.3.9.Italy
7.3.9.1.Market size and forecast, by type
7.3.9.2.Market size and forecast, by products and services
7.3.9.3.Market size and forecast, by end user
7.3.10.Germany
7.3.10.1.Market size and forecast, by type
7.3.10.2.Market size and forecast, by products and services
7.3.10.3.Market size and forecast, by end user
7.3.11.Rest of Europe
7.3.11.1.Market size and forecast, by type
7.3.11.2.Market size and forecast, by products and services
7.3.11.3.Market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by type
7.4.4.Market size and forecast, by products and services
7.4.5.Market size and forecast, by end user
7.4.6.Japan
7.4.6.1.Market size and forecast, by type
7.4.6.2.Market size and forecast, by products and services
7.4.6.3.Market size and forecast, by end user
7.4.7.China
7.4.7.1.Market size and forecast, by type
7.4.7.2.Market size and forecast, by products and services
7.4.7.3.Market size and forecast, by end user
7.4.8.Australia
7.4.8.1.Market size and forecast, by type
7.4.8.2.Market size and forecast, by products and services
7.4.8.3.Market size and forecast, by end user
7.4.9.India
7.4.9.1.Market size and forecast, by type
7.4.9.2.Market size and forecast, by products and services
7.4.9.3.Market size and forecast, by end user
7.4.10.South Korea
7.4.10.1.Market size and forecast, by type
7.4.10.2.Market size and forecast, by products and services
7.4.10.3.Market size and forecast, by end user
7.4.11.Taiwan
7.4.11.1.Market size and forecast, by type
7.4.11.2.Market size and forecast, by products and services
7.4.11.3.Market size and forecast, by end user
7.4.12.Rest of Asia-Pacific
7.4.12.1.Market size and forecast, by type
7.4.12.2.Market size and forecast, by products and services
7.4.12.3.Market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by type
7.5.4.Market size and forecast, by products and services
7.5.5.Market size and forecast, by end user
7.5.6.Brazil
7.5.6.1.Market size and forecast, by type
7.5.6.2.Market size and forecast, by products and services
7.5.6.3.Market size and forecast, by end user
7.5.7.Saudi Arabia
7.5.7.1.Market size and forecast, by type
7.5.7.2.Market size and forecast, by products and services
7.5.7.3.Market size and forecast, by end user
7.5.8.South Africa
7.5.8.1.Market size and forecast, by type
7.5.8.2.Market size and forecast, by products and services
7.5.8.3.Market size and forecast, by end user
7.5.9.Rest of LAMEA
7.5.9.1.Market size and forecast, by type
7.5.9.2.Market size and forecast, by products and services
7.5.9.3.Market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.FRESENIUS SE AND CO. KGAA
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.ASAHI KASEI CORPORATION
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.B. BRAUN MELSUNGEN AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.BAXTER INTERNATIONAL INC.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.DAVITA
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.ANGIODYNAMICS INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.DIAVERUM DEUTSCHLAND GmbH.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.NIKKISO CO. LTD.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.NIPRO CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.SIDE EFFECTS OF DIALYSIS
TABLE 02.ACCESS FISTULA AND GRAFTS
TABLE 03.ACCESS CATHETERS
TABLE 04.DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 05.DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 06.DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 07.HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 08.HEMODIALYSIS MARKET FOR SHORT DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 09.HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 10.DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 11.PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 12.PERITONEAL DIALYSIS MARKET FOR AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 13.DIALYSIS MARKET, BY PRODUCT AND SERVICES, 2020–2028 ($MILLION)
TABLE 14.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 15.DIALYSIS EQUIPMENT MARKET BY TYPE, BY REGION, 2020–2028 ($MILLION)
TABLE 16.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 17.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 18.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 19.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 20.DIALYSIS EQUIPMENT MARKET BY TYPE, BY REGION, 2020–2028 ($MILLION)
TABLE 21.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 22.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 23.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 24.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 25.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020–2028 ($MILLION)
TABLE 26.DIALYSIS MARKET, BY DIALYSIS SITE, 2020–2028 ($MILLION)
TABLE 27.DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2020–2028 ($MILLION)
TABLE 28.DIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2020–2028 ($MILLION)
TABLE 29.DIALYSIS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 30.NORTH AMERICA DIALYSIS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 31.NORTH AMERICA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 32.NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 33.NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 34.NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 35.NORTH AMERICA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 36.NORTH AMERICA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 37.NORTH AMERICA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 38.U.S. DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 39.U.S. HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 40.U.S. PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 41.U.S. DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 42.U.S. DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 43.U.S. DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 44.U.S. DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 45.CANADA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 46.CANADA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 47.CANADA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 48.CANADA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 49.CANADA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 50.CANADA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 51.CANADA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 52.CANADA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 53.CANADA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 54.CANADA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 55.CANADA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 56.CANADA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 57.CANADA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 58.CANADA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 59.EUROPE DIALYSIS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 60.EUROPE DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 61.EUROPE HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 62.EUROPE PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 63.EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 64.EUROPE DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 65.EUROPE DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 66.EUROPE DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 67.UK DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 68.UK HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 69.UK PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 70.UK DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 71.UK DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 72.UK DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 73.UK DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 74.FRANCE DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 75.FRANCE HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 76.FRANCE PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 77.FRANCE DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 78.FRANCE DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 79.FRANCE DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 80.FRANCE DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 81.SPAIN DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 82.SPAIN HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 83.SPAIN PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 84.SPAIN DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 85.SPAIN DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 86.SPAIN DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 87.SPAIN DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 88.ITALY DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 89.ITALY HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 90.ITALY PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 91.ITALY DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 92.ITALY DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 93.ITALY DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 94.ITALY DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 95.GERMANY DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 96.GERMANY HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 97.GERMANY PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 98.GERMANY DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 99.GERMANY DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 100.GERMANY DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 101.GERMANY DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 102.REST OF EUROPE DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 103.REST OF EUROPE HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 104.REST OF EUROPE PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 105.REST OF EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 106.REST OF EUROPE DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 107.REST OF EUROPE DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 108.REST OF EUROPE DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 109.ASIA-PACIFIC DIALYSIS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 110.ASIA-PACIFIC DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 111.ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 112.ASIA-PACIFIC PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 113.ASIA-PACIFIC DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 114.ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 115.ASIA-PACIFIC DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 116.ASIA-PACIFIC DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 117.JAPAN DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 118.JAPAN HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 119.JAPAN PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 120.JAPAN DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 121.JAPAN DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 122.JAPAN DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 123.JAPAN DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 124.CHINA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 125.CHINA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 126.CHINA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 127.CHINA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 128.CHINA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 129.CHINA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 130.CHINA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 131.AUSTRALIA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 132.AUSTRALIA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 133.AUSTRALIA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 134.AUSTRALIA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 135.AUSTRALIA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 136.AUSTRALIA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 137.AUSTRALIA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 138.INDIA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 139.INDIA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 140.INDIA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 141.INDIA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 142.INDIA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 143.INDIA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 144.INDIA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 145.SOUTH KOREA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 146.SOUTH KOREA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 147.SOUTH KOREA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 148.SOUTH KOREA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 149.SOUTH KOREA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 150.SOUTH KOREA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 151.SOUTH KOREA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 152.TAIWAN DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 153.TAIWAN HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 154.TAIWAN PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 155.TAIWAN DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 156.TAIWAN DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 157.TAIWAN DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 158.TAIWAN DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 159.REST OF ASIA-PACIFIC DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 160.REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 161.REST OF ASIA-PACIFIC PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 162.REST OF ASIA-PACIFIC DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 163.REST OF ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 164.REST OF ASIA-PACIFIC DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 165.REST OF ASIA-PACIFIC DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 166.LAMEA DIALYSIS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 167.LAMEA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 168.LAMEA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 169.LAMEA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 170.LAMEA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 171.LAMEA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 172.LAMEA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 173.LAMEA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 174.BRAZIL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 175.BRAZIL HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 176.BRAZIL PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 177.BRAZIL DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 178.BRAZIL DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 179.BRAZIL DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 180.BRAZIL DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 181.SAUDI ARABIA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 182.SAUDI ARABIA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 183.SAUDI ARABIA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 184.SAUDI ARABIA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 185.SAUDI ARABIA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 186.SAUDI ARABIA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 187.SAUDI ARABIA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 188.SOUTH AFRICA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 189.SOUTH AFRICA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 190.SOUTH AFRICA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 191.SOUTH AFRICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 192.SOUTH AFRICA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 193.SOUTH AFRICA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 194.SOUTH AFRICA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 195.REST OF LAMEA DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 196.REST OF LAMEA HEMODIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 197.REST OF LAMEA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 198.REST OF LAMEA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020–2028 ($MILLION)
TABLE 199.REST OF LAMEA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 200.REST OF LAMEA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 201.REST OF LAMEA DIALYSIS MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 202.FRESENIUS: COMPANY SNAPSHOT
TABLE 203.FRESENIUS: OPERATING SEGMENTS
TABLE 204.FRESENIUS: PRODUCT PORTFOLIO
TABLE 205.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 206.ASAHI KASEI: COMPANY SNAPSHOT
TABLE 207.ASAHI KASEI: OPERATING SEGMENTS
TABLE 208.ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 209.ASAHI KASEI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 210.B. BRAUN: COMPANY SNAPSHOT
TABLE 211.B. BRAUN: OPERATING SEGMENTS
TABLE 212.B. BRAUN: PRODUCT PORTFOLIO
TABLE 213.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 214.BAXTER: COMPANY SNAPSHOT
TABLE 215.BAXTER: OPERATING SEGMENTS
TABLE 216.BAXTER: PRODUCT PORTFOLIO
TABLE 217.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 218.BD: COMPANY SNAPSHOT
TABLE 219.BD: OPERATING SEGMENTS
TABLE 220.BD: PRODUCT PORTFOLIO
TABLE 221.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 222.DAVITA: COMPANY SNAPSHOT
TABLE 223.DAVITA: OPERATING SEGMENTS
TABLE 224.DAVITA: PRODUCT PORTFOLIO
TABLE 225.DAVITA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 226.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 227.ANGIODYNAMICS: PRODUCT SEGMENTS
TABLE 228.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 229.ANGIODYNAMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 230.DIAVERUM DEUTSCHLAND GMBH.: COMPANY SNAPSHOT
TABLE 231.DIAVERUM DEUTSCHLAND GMBH.: OPERATING SEGMENTS
TABLE 232.DIAVERUM DEUTSCHLAND GMBH.: PRODUCT PORTFOLIO
TABLE 233.DIAVERUM DEUTSCHLAND GMBH.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 234.NIKKISO: COMPANY SNAPSHOT
TABLE 235.NIKKISO: OPERATING SEGMENTS
TABLE 236.NIKKISO: PRODUCT PORTFOLIO
TABLE 237.NIKKISO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 238.NIPRO: COMPANY SNAPSHOT
TABLE 239.NIPRO: OPERATING SEGMENTS
TABLE 240.NIPRO: PRODUCT PORTFOLIO
TABLE 241.NIPRO: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURE
FIGURE 01.SEGMENTATION OF DIALYSIS MARKET
FIGURE 02.TOP INVESTMENT POCKETS IN DIALYSIS MARKET
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.RESTRAINTS AND DRIVERS: DIALYSIS MARKET
FIGURE 13.PROJECTED PREVALENCE OF CKD IN 2020 AND 2030 IN ADULTS AGED 30 YEARS OR OLDER (U.S.)
FIGURE 14.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
FIGURE 15.DIALYSIS REIMBURSEMENT SCENARIO AROUND THE WORLD
FIGURE 16.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY COUNTRY, 2020 & 2028 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 26.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 27.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 28.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 29.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 30.GLOBAL PREVALENCE OF DIALYSIS, RATE PER MILLION POPULATION (PMP), AGE ≥ 18 YEARS
FIGURE 31.TRENDS IN ANNUAL NUMBER OF ESRD INCIDENT CASES AND STANDARD INCIDENCES RATES PER MILLION EACH YEAR, U.S.
FIGURE 32.FRESENIUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 34.FRESENIUS: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 35.ASAHI KASEI: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.ASAHI KASEI: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 37.ASAHI KASEI: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 38.B. BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 40.B. BRAUN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 41.BAXTER: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.BAXTER: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43.BAXTER: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 44.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 46.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 47.DAVITA: NET SALES, 2018–2020 ($MILLION)
FIGURE 48.DAVITA: REVENUE SHARE, BY SEGMENTS, 2020 (%)
FIGURE 49.DAVITA: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 50.ANGIODYNAMICS: NET SALES, 2018–2020 ($MILLION)
FIGURE 51.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENTS, 2020 (%)
FIGURE 52.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 53.DIAVERUM DEUTSCHLAND GMBH.: NET SALES, 2018–2020 ($MILLION)
FIGURE 54.DIAVERUM DEUTSCHLAND GMBH.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 55.DIAVERUM DEUTSCHLAND GMBH.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 56.NIKKISO: NET SALES, 2018–2020 ($MILLION)
FIGURE 57.NIKKISO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 58.NIKKISO: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 59.NIPRO: NET SALES, 2018–2020 ($MILLION)
FIGURE 60.NIPRO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 61.NIPRO: REVENUE SHARE, BY REGION, 2020 (%)
Dialysis involves purification of blood by removing the toxins and other waste products formed in the blood due to inappropriate functioning of the kidneys. Dialysis has gained popularity as it is a preferred form of treatment of chronic renal diseases and kidney failures as compared to kidney transplantation. Furthermore, as some patients, such as those suffering from heart or liver disease are not eligible for kidney transplantation, the rise in the incidence of kidney failures is expected to propel the growth of the dialysis market. The lack of matching donors for kidney transplantation is expected to increase the demand for dialysis.
Increase in number of cases of end-stage renal diseases, rise in prevalence of diabetes, surge in funding for the development of new products with advanced technology, and growth in incidence of kidney failure propel the demand for dialysis market growth. However, the lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to prevent the market growth.
The peritoneal dialysis segment is expected to grow at a highest rate and provide lucrative opportunities for the market players. The advantages of peritoneal dialysis over hemodialysis, such as low number of clinical visits, negligible usage of needles, and easy-to-use machineries, are expected to boost the market for peritoneal dialysis.
The employment of dialysis is highest in North America, owing to the increase in adoption of these products, high prevalence rate of diabetes and hypertension, and growth in disposable income among customers. Although the use of dialysis in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase, owing to rise in disposable income, increase in incidence rate of kidney failure, and presence of large geriatric population.
A. No, there is no value chain analysis provided in the Dialysis Market report
A. The key trends in the Dialysis Market are increase in the number of ESRD, rise in incidence of diabetes and hypertension, and surge in funding for development of new products
A. The market value of Dialysis Market in 2028 was $129,756.8 Million
A. The top companies that hold the market share in Dialysis Market are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc and DaVita HealthCare Partners Inc.
A. The total market value of Dialysis Market is $ $91,205.0 million in 2020
A. The base year for the report is 2020
A. Yes, Dialysis Market companies are profiled in the report
A. The forecast period in the report is from 2021 to 2028
Start reading instantly.
This Report and over 68,131+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report